Wells Fargo Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $48

Benzinga Newsdesk www.benzinga.com Neutral 77.5%

Neg 0% Neu 77.5% Pos 0%

Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $50 to $48.